Skip to main content
. 2021 Oct 25;6(9-10):719–730. doi: 10.1016/j.jacbts.2021.08.002

Table 1.

Baseline Patient Characteristics

TAA Group (n = 36) Control Group (Aortic Valve Surgery) (n = 23) P Value
Age, y 65 (56-72) 70 (64-73) 0.13
Male 28 (77.8) 12 (52.2) 0.050
Height, cm 171 (165-180) 164 (158-178) 0.016
Weight, kg 82 (69-89) 75 (66-83) 0.21
BSA, m2 1.94 (1.77-2.07) 1.76 (1.72-2.01) 0.044
BMI, kg/m2 25.9 (25.2-28.4) 26.9 (24.5-28.1) 0.84
Family history of CVD 9 (25.0) 5 (21.7) 1.00
Tobacco use 0.80
 Active 9 (25.0) 4 (17.4)
 Former 5 (13.9) 4 (17.4)
 Ever 22 (61.1) 15 (65.2)
Liver disease 0 1 (4.4) 0.39
Alcoholism 0 1 (4.4) 0.39
Hypertension 28 (77.8) 20 (87.0) 0.50
Diabetes mellitus 1 (2.8) 3 (13.0) 0.29
Dyslipidemia 16 (44.4) 18 (78.3) 0.015
COPD 4 (11.1) 1 (4.4) 0.64
Obesity 2 (5.6) 0 0.52
Atrial fibrillation 0.30
 Permanent 1 (2.8) 3 (13.0)
 Paroxysmal 4 (11.1) 1 (4.4)
 Ever 31 (86.1) 19 (82.6)
Prior PM implantation 0 1 (4.4) 0.39
Prior AMI 0 0 1.00
Prior PCI 0 2 (8.7) 0.15
Prior CVA 0 1 (4.4) 0.39
Heart failure 1 (2.8) 0 1.00

Values are median (interquartile range) or n (%).

AMI = acute myocardial infarction; BMI = body mass index; BSA = body surface area; COPD = chronic obstructive pulmonary disease; CVA = cerebrovascular accident; CVD = cardiovascular disease; PCI = percutaneous coronary intervention; PM = pacemaker; TAA = thoracic aortic aneurysms.